Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications.

Superb K Misra1, Sabeel P Valappil, Ipsita Roy

  • 1Department of Materials, Imperial College London, Prince Consort Road, London SW7 2BP, UK.

Biomacromolecules
|August 15, 2006
PubMed
Summary

Polyhydroxyalkanoates (PHAs) are biodegradable polymers with diverse applications in tissue engineering. Composites of PHAs with inorganic materials enhance properties for advanced biomedical scaffolds.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sol-gel derived B<sub>2</sub>O<sub>3</sub>-CaO borate bioactive glasses with hemostatic, antibacterial and pro-angiogenic activities.

Regenerative biomaterials·2024
Same author

Editorial: Bioengineering of biomimetic microenvironments for cardiac tissue engineering.

Frontiers in bioengineering and biotechnology·2023
Same author

The Impact of 45S5-Bioactive Glass on Synovial Cells in Knee Osteoarthritis-An In Vitro Study.

Materials (Basel, Switzerland)·2023
Same author

Bioactive Glass and Silica Particles for Skeletal and Cardiac Muscle Tissue Regeneration.

Tissue engineering. Part B, Reviews·2023
Same author

Surface engineering of mesoporous bioactive glass nanoparticles with bacteriophages for enhanced antibacterial activity.

Colloids and surfaces. B, Biointerfaces·2023
Same author

Mending a broken heart by biomimetic 3D printed natural biomaterial-based cardiac patches: a review.

Frontiers in bioengineering and biotechnology·2023

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Tissue Engineering

Background:

  • Polyhydroxyalkanoates (PHAs) are a versatile class of biodegradable polymers with tunable mechanical properties, ranging from brittle to elastomeric.
  • PHAs are increasingly explored for biomedical applications including sutures, cardiovascular patches, wound dressings, and tissue engineering scaffolds.
  • Combining PHAs with inorganic phases is a strategy to enhance mechanical strength, control degradation rates, and introduce bioactivity.

Purpose of the Study:

  • To review international research on polyhydroxyalkanoate/inorganic phase composites.
  • To analyze investigated systems, microstructures, achieved properties, and applications, with a focus on tissue engineering scaffolds.
  • To discuss future prospects for developing optimized PHA/inorganic composites for improved tissue engineering.

Related Experiment Videos

Main Methods:

  • Literature review of international research on PHA/inorganic composites.
  • Analysis of composite systems, including polymer types (e.g., PHB, PHBV, PHBHx) and inorganic fillers (e.g., hydroxyapatite, bioactive glass).
  • Evaluation of microstructural characteristics, mechanical properties, degradation behavior, and bioactivity.

Main Results:

  • Various PHA/inorganic composite systems have been investigated, utilizing different polymers and fillers.
  • These composites demonstrate improved mechanical properties and tailored degradation profiles compared to neat PHAs.
  • Specific examples include composites with hydroxyapatite, bioactive glass, and glass-ceramics for enhanced performance.

Conclusions:

  • PHA/inorganic composites show significant promise for advanced tissue engineering scaffolds.
  • Further development focusing on optimized microstructures and properties is crucial for maximizing their potential.
  • These materials offer a pathway to creating next-generation regenerative medicine devices.